Inhibitors to factor VII in congenital factor VII deficiency
Copyright policy )Inhibitors to factor VII in congenital factor VII deficiency
We performed a prospective study of FVII inhibitor occurrence in a large number of patients with FVII deficiency who had received replacement therapy for spontaneous or traumatic bleeding episodes, major or minor surgical interventions or prophylaxis.Inhibitor development was detected in 2.6% (3/115) of patients, but the incidence of de novo inhibitors was 0.8% (1/115). Thus, in this rare bleeding disorder, the development of FVII inhibitors is a very rare complication as rare as that reported in patients with haemophilia B (prevalence of 2–3%)
- University of Palermo Argentina
- Aarhus University Hospital Denmark
- Shiraz University Iran (Islamic Republic of)
- University of Palermo Italy
- University of Ferrara Italy
Inhibitors, Factor VII Deficiency, rVIIa; FVII deficiency; Inhibitors, Factor VII deficiency, Humans, Factor VII, Inhibitors, Factor VII deficiency, Antibodies
Inhibitors, Factor VII Deficiency, rVIIa; FVII deficiency; Inhibitors, Factor VII deficiency, Humans, Factor VII, Inhibitors, Factor VII deficiency, Antibodies
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).26 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!